Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen Chronotherapy in Third Molar Extraction
NCT03789058Phase 3Unknown
- Sponsor
- Jordan University of Science and Technology
- Start
- Apr 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in postoperative pain and post-operative inflammation (2 arms), sponsored by Jordan University of Science and Technology. Primary endpoint: Visual Analog Scale Pain at 4 days. Status: unknown.
02
Drugs
ibuprofen
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT03789058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789058.